SCHEMBL8212405

SCHEMBL8212405

CC(C)CN1C(=O)C2(CCN(C(=O)N[C@H](C)c3ccc(F)cc3)CC2)C1c1ccc(Cl)cc1

nearest known ligand 0.71

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 18/20 0.71
TRPV1 Q8NER1 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12876984 1.00 CACNA1H (0.71) CACNA1HTRPV1
SCHEMBL12877006 0.87 CACNA1H (0.72) CACNA1H
SCHEMBL12877017 0.83 CACNA1H (0.78) CACNA1HTRPV1
SCHEMBL13596147 0.83 CACNA1H (0.70) CACNA1H
SCHEMBL8214077 0.83 CACNA1H (1.00) CACNA1HTRPV1
SCHEMBL8202156 0.83 CACNA1H (1.00) CACNA1HTRPV1
SCHEMBL12876991 0.81 CACNA1H (0.71) CACNA1HTRPV1
SCHEMBL13596146 0.79 CACNA1H (0.65) CACNA1H
SCHEMBL12876070 0.78 CACNA1H (0.75) CACNA1HTRPV1
SCHEMBL8202159 0.78 CACNA1H (1.00) CACNA1HTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033464-A2 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE LIPID METABOLISM SCHERING CORPORATION (US) 2008-03-20 WO disclosed